Physical rehabilitation program for cardiorespiratory health and quality of life among breast cancer survivors in UAE: a randomized control trial

Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In t...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 25; no. 1; pp. 705 - 12
Main Authors Rashid, Fatima Abdul, Anwar, Wajiha, Kandakurti, Praveen Kumar, Al Qawasmeh, Khaled H. A., Latif, Muhammad Farooq, Tirmazy, Syed Hammad, Omara, Mohamed, Hazari, Animesh
Format Journal Article
LanguageEnglish
Published London BioMed Central 16.04.2025
BioMed Central Ltd
BMC
Subjects
Adolescent
Adult
Aerobics
Aged
Biomedical and Life Sciences
Biomedicine
Breast cancer
Breast Cancer survivors
Breast Neoplasms - rehabilitation
Breast Neoplasms - therapy
Cancer Research
Cancer Survivors
Cancer therapies
Cardiac output
Cardiorespiratory Fitness
Care and treatment
Chemotherapy
Clinical trials
Compliance
Complications
Double-Blind Method
Dyspnea
Exercise
Exercise Therapy - methods
Female
Health aspects
Health Promotion and Disease Prevention
Hospitals
Humans
Immunoglobulins
Intervention
Medicine/Public Health
Methods
Middle Aged
Mortality
Oncology
Physical fitness
Physical therapy
Physical Therapy Modalities
Pulmonary ventilation
Quality of Life
Quality of life and supportive care in cancer
Radiation therapy
Rehabilitation
Respiration
Surgery
Surgical Oncology
Therapeutics, Physiological
United Arab Emirates
United Arab Emirates - epidemiology
Young Adult
United Arab Emirates
Dubai United Arab Emirates
Cardiorespiratory fitness
Rehabilitation
United Arab Emirates
Breast Cancer survivors
Quality of life
Online AccessGet full text
ISSN1471-2407
1471-2407
DOI10.1186/s12885-025-14005-2

Cover

Abstract Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. Objective To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. Methodology: Design Parallel-group, randomized controlled trial Participants and Setting The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18–65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. Interventions The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). Outcome The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO 2 peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded. Results A total of 62 breast cancer survivors were randomly allocated to the intervention group ( n  = 31) and the control group ( n  = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO 2 peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p  < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances ( p  < 0.05). Conclusions The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months. Clinical Trials Registration Number Clinical Trials.gov NCT06013527. Registered on 28 August 2023.
AbstractList BackgroundBreast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce.ObjectiveTo analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program.Methodology: DesignParallel-group, randomized controlled trialParticipants and SettingThe study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18–65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital.InterventionsThe intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research).OutcomeThe changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO2peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded.ResultsA total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05).ConclusionsThe intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months.Clinical Trials Registration NumberClinical Trials.gov NCT06013527. Registered on 28 August 2023.
Abstract Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. Objective To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. Methodology: Design Parallel-group, randomized controlled trial Participants and Setting The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18–65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. Interventions The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). Outcome The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO2peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded. Results A total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05). Conclusions The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months. Clinical Trials Registration Number Clinical Trials.gov NCT06013527. Registered on 28 August 2023.
Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce.BACKGROUNDBreast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce.To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program.OBJECTIVETo analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program.DESIGN: Parallel-group, randomized controlled trial PARTICIPANTS AND SETTING: The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18-65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital.METHODOLOGYDESIGN: Parallel-group, randomized controlled trial PARTICIPANTS AND SETTING: The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18-65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital.The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research).INTERVENTIONSThe intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research).The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO2peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded.OUTCOMEThe changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO2peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded.A total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05).RESULTSA total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05).The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months.CONCLUSIONSThe intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months.Clinical Trials.gov NCT06013527. Registered on 28 August 2023.CLINICAL TRIALS REGISTRATION NUMBERClinical Trials.gov NCT06013527. Registered on 28 August 2023.
Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. Objective To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. Methodology: Design Parallel-group, randomized controlled trial Participants and Setting The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18–65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. Interventions The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). Outcome The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO 2 peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded. Results A total of 62 breast cancer survivors were randomly allocated to the intervention group ( n  = 31) and the control group ( n  = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO 2 peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p  < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances ( p  < 0.05). Conclusions The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months. Clinical Trials Registration Number Clinical Trials.gov NCT06013527. Registered on 28 August 2023.
Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. DESIGN: Parallel-group, randomized controlled trial PARTICIPANTS AND SETTING: The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18-65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded. A total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05). The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months. Clinical Trials.gov NCT06013527. Registered on 28 August 2023.
Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. Objective To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. Methodology: Design Parallel-group, randomized controlled trial Participants and Setting The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18-65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. Interventions The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). Outcome The changes in cardiorespiratory fitness were assessed by measuring peak oxygen uptake (VO.sub.2peak) during a 2 km walk test using Cosmed fitmate Pro and Peak Expiratory Flow Rate (PEFR) was assessed using a peak flow meter. The HRQoL was measured by the QLQ-C30 questionnaire. Outcomes were measured at baseline, post-intervention, and 3 months post-intervention. Allocation of intervention was not blinded due to the nature of the intervention; however, the outcome accessors were blinded. Results A total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO.sub.2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05). Conclusions The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months. Clinical Trials Registration Number Clinical Trials.gov NCT06013527. Registered on 28 August 2023. Keywords: Breast Cancer survivors, Cardiorespiratory fitness, Quality of life, Rehabilitation, United Arab Emirates
Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment survivors are reported to have significantly poor cardiovascular fitness which affects their health-related quality of life (HRQoL). In the United Arab Emirates (UAE), evidence for practice addressing post-treatment concerns is scarce. To analyse the changes in cardiorespiratory fitness and HRQoL domains for breast cancer survivors in the UAE using a 2-month physical rehabilitation program. Parallel-group, randomized controlled trial The study included breast cancer survivors who were treated with chemotherapy and/or radiotherapy, aged 18-65 years, and able to provide informed consent. Participants were recruited by referral from Al Tawam Hospital, a national referral center for oncology, and Dubai Hospital. The intervention group (IG) received a 2-month supervised physical rehabilitation program focusing on aerobic training with 2 supervised sessions and 3 at-home sessions per week. The sessions were held at Thumbay Physical Therapy and Rehabilitation Hospital. The control group (CG) received standard care at their treatment facility. Randomization for subject allocation was double-blinded (conducted by a third party not involved in the research). A total of 62 breast cancer survivors were randomly allocated to the intervention group (n = 31) and the control group (n = 31). Data from all participants who completed the 5-month trial was analyzed. The intervention group showed a significant improvement from baseline to follow-up in terms of cardiorespiratory fitness: VO.sub.2peak increased by 8.3 ± 4.6 ml/kg/min and PEFR by 81 ± 2.73 L/min, while the control group demonstrated a decrease of 1.1 ± 2.1 ml/kg/min and 4 ± 2.48 L/min, respectively (between-group difference, p < 0.001 for both measures). The intervention program was also significantly effective in improving HRQoL in all functional domains except cognitive and social, and there was a notable reduction in the symptoms of fatigue, dyspnea, pain, and sleep disturbances (p < 0.05). The intervention group showed significant improvement in cardiorespiratory fitness and multiple domains of HRQoL among breast cancer survivors in the UAE, which were sustained at 3 months.
ArticleNumber 705
Audience Academic
Author Al Qawasmeh, Khaled H. A.
Kandakurti, Praveen Kumar
Omara, Mohamed
Latif, Muhammad Farooq
Rashid, Fatima Abdul
Tirmazy, Syed Hammad
Hazari, Animesh
Anwar, Wajiha
Author_xml – sequence: 1
  givenname: Fatima Abdul
  surname: Rashid
  fullname: Rashid, Fatima Abdul
  organization: College of Health Sciences, Gulf Medical University
– sequence: 2
  givenname: Wajiha
  surname: Anwar
  fullname: Anwar, Wajiha
  organization: College of Health Sciences, Gulf Medical University
– sequence: 3
  givenname: Praveen Kumar
  surname: Kandakurti
  fullname: Kandakurti, Praveen Kumar
  email: dean.coahs@gmu.ac.ae
  organization: College of Health Sciences, Gulf Medical University
– sequence: 4
  givenname: Khaled H. A.
  surname: Al Qawasmeh
  fullname: Al Qawasmeh, Khaled H. A.
  organization: Al Tawam Hospital
– sequence: 5
  givenname: Muhammad Farooq
  surname: Latif
  fullname: Latif, Muhammad Farooq
  organization: Dubai Hospital, Dubai Health
– sequence: 6
  givenname: Syed Hammad
  surname: Tirmazy
  fullname: Tirmazy, Syed Hammad
  organization: Dubai Hospital, Dubai Health
– sequence: 7
  givenname: Mohamed
  surname: Omara
  fullname: Omara, Mohamed
  organization: Dubai Hospital, Dubai Health
– sequence: 8
  givenname: Animesh
  surname: Hazari
  fullname: Hazari, Animesh
  email: dr.animesh@gmu.ac.ae
  organization: College of Health Sciences, Gulf Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40241061$$D View this record in MEDLINE/PubMed
BookMark eNp9k11v0zAUhiM0xD7gD3CBLCEhuMiwnTh1uUHVNKDSJBCwa-vEOU5dJXZnJxXlX_CPcdextQghX8Rynve1z9dpduS8wyx7zug5Y7J6GxmXUuSUi5yVlIqcP8pOWDlhOS_p5Ghvf5ydxriklE0klU-y45LyktGKnWS_viw20WroSMAF1LazAwzWO7IKvg3QE-MD0RAa6wPGlQ0w-LAhC4RuWBBwDbkZIYk2xBvSWYMEeu9aUgeEOCSl0xhIHMParn2IxDpyPbt8R4CEJPa9_YkN0d4NwXdkCBa6p9ljA13EZ3ffs-z6w-X3i0_51eeP84vZVa4rXg15QYvGTMtGMAO6YkJjPZUl1MBZM-GV0YgohWGc1kYaMQHGKCsr3qAWk6qqi7NsvvNtPCzVKtgewkZ5sOr2wIdWQRis7lCZsiqpbApWIy0bI8HQQlM6laLgFFmRvN7vvFZj3WOjMcUD3YHp4R9nF6r1a5WeR1khWXJ4fecQ_M2IcVC9jRq7Dhz6MaqCTVkqJxdb9OVf6NKPwaVcqfQcJniKkj5QLaQIrDM-Xay3pmomCzHllaxEos7_QaXVYG9TWdDYdH4geHMg2JYOfwwtjDGq-bevh-yrPXbXMtF347a_4iH4Yj9993n706YJ4DtABx9jQHOPMKq2s6B2s6DSLKjbWVA8iYqdKCbYtRge8vQf1W_dNwry
Cites_doi 10.1093/annonc/mds342
10.3389/frhs.2024.1329252
10.1139/H09-045
10.3390/cancers15133380
10.1188/12.CJON.293-300
10.3389/fonc.2021.669078/full
10.1001/jamacardio.2023.3558
10.1186/s12885-021-08716-5
10.1002/pon.1837
10.1186/s12890-024-02890-5
10.1249/MSS.0000000000002116
10.1007/s10549-024-07278-x
10.1007/s10549-022-06759-1
10.3322/caac.21834
10.1353/pbm.2019.0046
10.1016/j.jpainsymman.2021.07.025
10.1016/j.jpainsymman.2021.09.011
10.1186/s13058-018-1051-6
10.1186/s12955-020-01591-x
10.1007/s11764-023-01455-5
10.1007/s12282-014-0521-7
10.3109/09638288.2015.1107633
10.70252/OOAQ4294
10.1016/j.jclinepi.2010.03.004
10.1016/j.amjcard.2019.12.019
10.1097/PHM.0000000000001017
10.1186/2193-1801-2-68
10.3233/BD-249005
10.1007/s12282-022-01347-z
10.1016/j.jshs.2023.10.010
10.1007/s40487-023-00225-8
10.1007/s00508-020-01739-1
10.1186/s13063-024-08192-9
10.3389/fonc.2022.955505
10.1055/s-2007-1024694
10.1148/radiol.2021203476
10.4048/jbc.2015.18.1.87
10.1007/s11764-009-0110-5
10.3390/cancers16101912
10.21873/invivo.11554
10.2147/BCTT.S82039
10.3389/fcvm.2019.00069
10.1186/s12916-015-0513-2
10.1016/j.ejca.2022.10.026
10.70252/AJQK9649
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12885-025-14005-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Physical Therapy
EISSN 1471-2407
EndPage 12
ExternalDocumentID oai_doaj_org_article_f46408d31be04df8af03c00985320e13
PMC12001381
A835926865
40241061
10_1186_s12885_025_14005_2
Genre Randomized Controlled Trial
Journal Article
GeographicLocations United Arab Emirates
Dubai United Arab Emirates
GeographicLocations_xml – name: United Arab Emirates
– name: Dubai United Arab Emirates
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
LGEZI
LOTEE
M1P
M48
M~E
NADUK
NXXTH
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c626t-303df94d51fac615ceb984aba21d726fceee85f120bf8f57a1101462dec5766b3
IEDL.DBID M48
ISSN 1471-2407
IngestDate Wed Aug 27 00:59:46 EDT 2025
Thu Aug 21 18:30:50 EDT 2025
Fri Sep 05 17:32:18 EDT 2025
Fri Jul 25 10:43:53 EDT 2025
Tue Jun 17 21:59:28 EDT 2025
Tue Jun 10 20:58:38 EDT 2025
Fri Jun 27 05:14:14 EDT 2025
Thu May 22 21:23:07 EDT 2025
Sun Apr 20 01:20:53 EDT 2025
Tue Jul 01 05:13:00 EDT 2025
Sat Sep 06 07:28:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cardiorespiratory fitness
Rehabilitation
United Arab Emirates
Breast Cancer survivors
Quality of life
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c626t-303df94d51fac615ceb984aba21d726fceee85f120bf8f57a1101462dec5766b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.proquest.com/docview/3201524620?pq-origsite=%requestingapplication%
PMID 40241061
PQID 3201524620
PQPubID 44074
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_f46408d31be04df8af03c00985320e13
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12001381
proquest_miscellaneous_3191147251
proquest_journals_3201524620
gale_infotracmisc_A835926865
gale_infotracacademiconefile_A835926865
gale_incontextgauss_ISR_A835926865
gale_healthsolutions_A835926865
pubmed_primary_40241061
crossref_primary_10_1186_s12885_025_14005_2
springer_journals_10_1186_s12885_025_14005_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-04-16
PublicationDateYYYYMMDD 2025-04-16
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-16
  day: 16
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC cancer
PublicationTitleAbbrev BMC Cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References 14005_CR28
14005_CR48
M Evenepoel (14005_CR37) 2022; 63
NQ Agussalim (14005_CR35) 2024; 43
HM Penttinen (14005_CR22) 2011; 20
14005_CR1
14005_CR3
14005_CR2
JM Canada (14005_CR26) 2020; 125
14005_CR5
14005_CR10
14005_CR32
14005_CR4
14005_CR31
14005_CR7
14005_CR30
14005_CR6
14005_CR9
14005_CR14
14005_CR8
14005_CR13
FA Rashid (14005_CR29) 2024; 25
14005_CR12
14005_CR34
14005_CR11
14005_CR33
14005_CR18
14005_CR17
14005_CR39
14005_CR16
14005_CR15
14005_CR19
SD Herrmann (14005_CR24) 2024; 13
IHC Wu (14005_CR36) 2022; 63
D Moher (14005_CR21) 2010; 63
T Short (14005_CR38) 2022; 15
P Oja (14005_CR25) 1991; 12
14005_CR43
14005_CR20
14005_CR42
14005_CR41
K Cocks (14005_CR27) 2023; 178
14005_CR40
14005_CR47
H Penttinen (14005_CR23) 2019; 33
14005_CR46
14005_CR45
14005_CR44
References_xml – ident: 14005_CR43
  doi: 10.1093/annonc/mds342
– ident: 14005_CR47
  doi: 10.3389/frhs.2024.1329252
– ident: 14005_CR32
  doi: 10.1139/H09-045
– ident: 14005_CR16
  doi: 10.3390/cancers15133380
– ident: 14005_CR20
  doi: 10.1188/12.CJON.293-300
– ident: 14005_CR48
  doi: 10.3389/fonc.2021.669078/full
– ident: 14005_CR28
  doi: 10.1001/jamacardio.2023.3558
– ident: 14005_CR6
  doi: 10.1186/s12885-021-08716-5
– volume: 20
  start-page: 1211
  issue: 11
  year: 2011
  ident: 14005_CR22
  publication-title: Psychooncology
  doi: 10.1002/pon.1837
– ident: 14005_CR8
  doi: 10.1186/s12890-024-02890-5
– ident: 14005_CR42
  doi: 10.1249/MSS.0000000000002116
– ident: 14005_CR4
– ident: 14005_CR41
  doi: 10.1007/s10549-024-07278-x
– ident: 14005_CR9
  doi: 10.1007/s10549-022-06759-1
– ident: 14005_CR2
  doi: 10.3322/caac.21834
– ident: 14005_CR1
  doi: 10.1353/pbm.2019.0046
– volume: 63
  start-page: e1
  issue: 1
  year: 2022
  ident: 14005_CR36
  publication-title: J Pain Symptom Manage
  doi: 10.1016/j.jpainsymman.2021.07.025
– volume: 63
  start-page: e317
  issue: 3
  year: 2022
  ident: 14005_CR37
  publication-title: J Pain Symptom Manage
  doi: 10.1016/j.jpainsymman.2021.09.011
– ident: 14005_CR30
  doi: 10.1186/s13058-018-1051-6
– ident: 14005_CR12
  doi: 10.1186/s12955-020-01591-x
– ident: 14005_CR19
  doi: 10.1007/s11764-023-01455-5
– ident: 14005_CR15
  doi: 10.1007/s12282-014-0521-7
– ident: 14005_CR39
  doi: 10.3109/09638288.2015.1107633
– volume: 15
  start-page: 1444
  issue: 3
  year: 2022
  ident: 14005_CR38
  publication-title: Int J Exerc Sci
  doi: 10.70252/OOAQ4294
– volume: 63
  start-page: e1
  issue: 8
  year: 2010
  ident: 14005_CR21
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.03.004
– volume: 125
  start-page: 988
  issue: 6
  year: 2020
  ident: 14005_CR26
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2019.12.019
– ident: 14005_CR10
  doi: 10.1097/PHM.0000000000001017
– ident: 14005_CR7
  doi: 10.1186/2193-1801-2-68
– volume: 43
  start-page: 161
  issue: 1
  year: 2024
  ident: 14005_CR35
  publication-title: Breast Dis
  doi: 10.3233/BD-249005
– ident: 14005_CR11
  doi: 10.1007/s12282-022-01347-z
– volume: 13
  start-page: 6
  issue: 1
  year: 2024
  ident: 14005_CR24
  publication-title: J Sport Heal Sci
  doi: 10.1016/j.jshs.2023.10.010
– ident: 14005_CR40
  doi: 10.1007/s40487-023-00225-8
– ident: 14005_CR14
  doi: 10.1007/s00508-020-01739-1
– volume: 25
  start-page: 354
  issue: 1
  year: 2024
  ident: 14005_CR29
  publication-title: Trials
  doi: 10.1186/s13063-024-08192-9
– ident: 14005_CR34
  doi: 10.3389/fonc.2022.955505
– ident: 14005_CR3
– volume: 12
  start-page: 356
  issue: 04
  year: 1991
  ident: 14005_CR25
  publication-title: Int J Sports Med
  doi: 10.1055/s-2007-1024694
– ident: 14005_CR5
  doi: 10.1148/radiol.2021203476
– ident: 14005_CR18
– ident: 14005_CR13
  doi: 10.4048/jbc.2015.18.1.87
– ident: 14005_CR31
  doi: 10.1007/s11764-009-0110-5
– ident: 14005_CR44
  doi: 10.3390/cancers16101912
– volume: 33
  start-page: 881
  issue: 3
  year: 2019
  ident: 14005_CR23
  publication-title: Vivo (Brooklyn)
  doi: 10.21873/invivo.11554
– ident: 14005_CR46
  doi: 10.2147/BCTT.S82039
– ident: 14005_CR33
  doi: 10.3389/fcvm.2019.00069
– ident: 14005_CR45
  doi: 10.1186/s12916-015-0513-2
– volume: 178
  start-page: 128
  year: 2023
  ident: 14005_CR27
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2022.10.026
– ident: 14005_CR17
  doi: 10.70252/AJQK9649
SSID ssj0017808
Score 2.4454217
Snippet Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However,...
Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However, post-treatment...
Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However,...
BackgroundBreast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However,...
Abstract Background Breast cancer treatment has improved significantly, contributing to a 5-year relative survival rate of 99% for localized cases. However,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 705
SubjectTerms Adolescent
Adult
Aerobics
Aged
Biomedical and Life Sciences
Biomedicine
Breast cancer
Breast Cancer survivors
Breast Neoplasms - rehabilitation
Breast Neoplasms - therapy
Cancer Research
Cancer Survivors
Cancer therapies
Cardiac output
Cardiorespiratory Fitness
Care and treatment
Chemotherapy
Clinical trials
Compliance
Complications
Double-Blind Method
Dyspnea
Exercise
Exercise Therapy - methods
Female
Health aspects
Health Promotion and Disease Prevention
Hospitals
Humans
Immunoglobulins
Intervention
Medicine/Public Health
Methods
Middle Aged
Mortality
Oncology
Physical fitness
Physical therapy
Physical Therapy Modalities
Pulmonary ventilation
Quality of Life
Quality of life and supportive care in cancer
Radiation therapy
Rehabilitation
Respiration
Surgery
Surgical Oncology
Therapeutics, Physiological
United Arab Emirates
United Arab Emirates - epidemiology
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SB_FFrJ9rq0YRfNClSS6bzfp2SksVKqIe9C3ksx7oruzeCfpf-B87yeau3Yr44utmAtmZSWaGmfkNQk_jUCvLZ6HkwrCSU8fKRjesDBFrzhpNdYjdyCfvxPGCvz2tTi-M-oo1YSM88Mi4g8AFJ9LNqPGEuyB1IDMbUTDjRAOf5tUy0pBNMJXzB7UkctMiI8XBAK-wjJ3IVQkBBalKNjFDCa3_zzf5glG6XDB5KWuajNHRDXQ9e5F4Pp5-F13x7U109STnyW-hX-8z-3E_QeLGuRwLg6uKbSpF7c9z7XhsisS6dXhstvyBu4C_LIPHaSgRNrGEfQU7QVV6PKzhnfne9QNetngxP3yJNQbT57qvy5_e4VwFj9NgkNtocXT46fVxmYcvlBZinFUJps2FhruKBm3B7bHeNJJroxl1NRMBjKuXVaCMmCBDVWsap_4K5ryFEEaY2R2003atv4cwOJG1J94yYhsefC1prSXnFbeBEsNDgZ5vZKG-jRgbKsUmUqhRcgokp5LkFCvQqyiuLWXEx04fQGtU1hr1L60p0KMobDXydXvL1Rwc0oYJKaoCPUkUESOjjUU4Z3o9DOrNxw8TomeZKHSgGFbnngb47wirNaHcn1DCJbbT5Y3WqfyIDAqOCt4V8JQU6PF2Oe6MhXGt79ZAA_E25TV4qQW6OyrpljMc_K8Y8RdITtR3wrrpSrv8nCDGKUspbNj6YqPp5-f6u2zu_w_Z7KFrLN7UCKgp9tHOql_7B-D5rczDdMl_A6GfVHE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifl_11CiCD1quSdM09UVWueMUTkRduLeQpsm5oO3Z7gr6X_gfO5Nmd-2JvjYTaDOT-ejM_IaQJzjUyorcp0LWPBWs4WllKp56xJqztWHGYzfy8Tt5NBdvT4qT-MNtiGWVa50YFHXTWfxHvp-DpSq4kDx7efYtxalRmF2NIzQukksBugzkuTzZBFysVJlaN8oouT-ALlbYj1ykEFZkRconxihg9v-tmf8wTefLJs_lToNJOrxGrkZfks5G5l8nF1x7g1w-jtnym-TX-8gE2k_wuGksyqLgsFIbClL7bcadjq2R1LQNHVsuf9DO0y8L72gYTURrLGRfwk4QmJ4OK9A237t-oIuWzmcHL6ihYACb7uvip2torIWnYTzILTI_PPj0-iiNIxhSC5HOMgUD1_hKNAXzxoLzY11dKWFqw1lTcunBxDpVeMaz2itflIbh7F_JG2chkJF1fpvstF3rdgkFV7J0mbM8s5XwrlSsNEqIQljPslr4hDxb80KfjUgbOkQoSuqRcxo4pwPnNE_IK2TXhhJRssODrj_V8dJpL6TIVJOz2mWi8cr4LLeIoIrTMBzLE_IQma3Hc93cdT0Dt7TiUskiIY8DBSJltFiKc2pWw6DffPwwIXoaiXwHgmFN7GyA70ZwrQnl3oQSrrKdLq-lTkdVMuit4Cfk0WYZd2J5XOu6FdBA1M1ECb5qQu6MQro5GQFeGMb9CVET8Z0c3XSlXXwOQOOMh0Q2bH2-lvTte_2bN3f__xn3yBWOdxABM-Ue2Vn2K3cfPLtl_SBc39-lb0yX
  priority: 102
  providerName: ProQuest
– databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA9ygvgi53fPU6MIPmgxyaZp6tsqd5zCiagL9xaSNLlb0FbaXUH_C_9jJ2nas6c--LqZQDfzzcz8BqEnYamV5Qufc2FYzmnN8kpXLPcBa84aTbUP08jH78TRir89KU7SUFg_druPJcloqaNaS_GiB0sqwzRxkUNSQIocDO_lAnL3oI4rtpxqB6UkchyP-eu9mQuKSP1_2uPfHNLFZskLFdPoiA530bUUQeLlwPLr6JJrbqArx6lGfhP9fJ-eHnczFG6cWrEwhKnYxjbU7rzOjoeBSKybGg-Dlt9x6_HntXc4LiTCJrSvb-AmiEmH-y3YmG9t1-N1g1fLg5dYY3B7dftl_cPVOHXA47gU5BZaHR58en2Up8ULuYX8ZpODW6t9xeuCem0h5LHOVJJroxmtSyY8OFYnC08ZMV76otQ0bPwVrHYW0hdhFrfRTtM27i7CEECWjjjLiK24d6WkpZacF9x6Sgz3GXo28kJ9HfA1VMxLpFAD5xRwTkXOKZahV4FdE2XAxo4_tN2pSqqmPBecyHpBjSO89lJ7srABNzXswHB0kaGHgdlqeNdJw9USgtGKCSmKDD2OFAEfowkNOKd62_fqzccPM6Knici3IBhWp3kG-N8BUmtGuT-jBAW28-NR6lQyIL2CT4XICt6UZOjRdBxuhqa4xrVboIFcm_ISItQM3RmEdHoZDrFXyPYzJGfiO3u6-UmzPovw4pTF8jVcfT5K-vl3_Zs3e_9Hfg9dZUEnA2ym2Ec7m27r7kN8tzEPojr_Ama_Sao
  priority: 102
  providerName: Springer Nature
Title Physical rehabilitation program for cardiorespiratory health and quality of life among breast cancer survivors in UAE: a randomized control trial
URI https://link.springer.com/article/10.1186/s12885-025-14005-2
https://www.ncbi.nlm.nih.gov/pubmed/40241061
https://www.proquest.com/docview/3201524620
https://www.proquest.com/docview/3191147251
https://pubmed.ncbi.nlm.nih.gov/PMC12001381
https://doaj.org/article/f46408d31be04df8af03c00985320e13
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1ti9MwOJx3IH4R362eM4rgB-3ZZGmaCiLb2HEKO47pYPglpGlyDs5W2008_4X_2Cdpt9nzBL8UtjwZWZ73Pm8IPXNDrTTr25DxjIaM5DRMVUpD63rN6UwRZV018uSYH83Y-3k830HrcUftBdaXunZuntSsOjv48e38LTD8G8_wgr-qQcYKV2cch-AuRHEIInkPNBN3ztiEbaMKifAT6ggIZBdVSNZFNJf-RkdR-X7-f0vtP9TWxZTKC3FVr64Ob6DrrZ2JBw1h3EQ7priFrk7aSPpt9OukRRCuOr26cZuwhcGYxdonq1bbaDxuyiaxKnLclGOe49Lis4U12I8twplLcl_CTiCmCtcrkETfy6rGiwLPBuPXWGFQjnn5ZfHT5LjNk8d-dMgdNDscfxwdhe14hlCDF7QMQfnlNmV5TKzSYBhpk6WCqUxRkieUW1C_RsSW0CizwsaJIm4uMKe50eDk8Kx_F-0WZWHuIwxmZmIio2mkU2ZNIkiiBGMx05ZEGbMBerHGhfzadOGQ3nsRXDaYk4A56TEnaYCGDl0bSNdB239RVqeyZUhpGWeRyPskMxHLrVA26mvXXdVNyjCkH6DHDtmyudeNHJADMFlTygWPA_TUQ7guGoVL0zlVq7qW7z5MO0DPWyBbAmFo1VY9wP92jbc6kPsdSGBz3V1eU51cc4mEo4L9BXcaBejJZtntdKlzhSlXAAMeOVA82LEButcQ6eZmGFho7p1AgESHfDtX110pFp99E3JCfZAbtr5cU_r2XP_GzYP_OOdDdI06RnQdNfk-2l1WK_MITL9l1kNXknnSQ3vD8fHJFD6N-KjnX6P0PKfDczr8BM8ZHfwGNDBaCw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwEviP8EBjMIxANES1zHcZAQ6mBTy9ZqGqu0N-M49qgEyUha0PgWfBE-I2cnackQvO01PkeJf-e7s-8fQk9tUytF-8anLCU-DTPiJzIhvrG15lQqQ2lsNvJ4woZT-v44Ol5Dv9pcGBtW2cpEJ6izQtk78q0-aKqIUEaCN6dffds1ynpX2xYaNVvs6bPvcGSrXo_eAb7PCNndOXo79JuuAr4C433ug8zOTEKzKDRSgT5XOk04lakkYRYTZkBraB6ZkASp4SaKZWjb2TKSaQW2OUv78N5LaJ3ajNYeWt_emRwcLv0WMQ94m5rD2VYF0p_bDOjIh4NMEPmko_5cl4C_dcEfyvB8oOY5b61TgrvX0bXGesWDmt1uoDWd30SXx41__hb6edDAjstOBXDchIFhMJGxciGw5crHj-tkTCzzDNdJnme4MPjzzGjsmiHh1IbOz2EmsGiJqwXIt29FWeFZjqeDnVdYYlC5WfFl9kNnuIm-x64hyW00vRB47qBeXuT6HsJgvMY60IoEKqFGxzyMJac0osqEQUqNh160WIjTuraHcGcizkSNnADkhENOEA9tW7iWlLYut3tQlCei2ebCUEYDnvXDVAc0M1yaoK9szVbbf0OHfQ9tWrBFva5L6SIGYAgnhHEWeeiJo7C1OXIb_HMiF1UlRh8OO0TPGyJTAGMo2eRSwH_bcl4dyo0OJQgP1R1uuU40wqsSq63mocfLYTvTBuTlulgADZzzQxqDdeyhuzWTLleGgt1nbxo8xDvs21m67kg---RKm4fEuc5h6suW01ff9W9s7v__NzbRleHReF_sjyZ7D9BVYvejLdfJNlBvXi70Q7Ar5-mjZjNj9PGi5cdvYoOLvg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkSouiDeBQg1C4gBRY6_jONyW0lULtKqAlXqzHMduV4KkSrJI8C_4x8w42W1T4MB1PZaynrdm5htCXuBSKysmPhay4LFgJY9zk_PYI9acLQwzHqeRD4_k_ly8P0lPLk3xh273VUmyn2lAlKaq2zkvfa_iSu60YFUVThanMSQISRqDEb4u0PVhuVburusImUrUalTmr_dG7iig9v9pmy85p6uNk1eqp8EpzW6Rm0M0Sac9-2-Ta666QzYPh3r5XfLreGADbUaI3HRoy6IQslIbWlKbi5o77YcjqalK2g9d_qC1p18X3tGwnIgW2MrewU0QmYa2S7A33-umpYuKzqd7b6ih4ALL-tvipyvp0A1Pw4KQe2Q-2_uyux8PSxhiC7lOF4OLK30uypR5YyH8sa7IlTCF4azMuPTgZJ1KPeNJ4ZVPM8Nw-6_kpbOQyshicp9sVHXlHhIKwWTmEmd5YnPhXaZYZpQQqbCeJYXwEXm14oU-77E2dMhRlNQ95zRwTgfOaR6Rt8iuNSXiZIcf6uZUD2qnvZAiUeWEFS4RpVfGJxOLGKq4D8OxSUS2kdm6f9e1tuspBKY5l0qmEXkeKBAro8JmnFOzbFt98PnTiOjlQORrEAxrhtkG-N8IrzWi3BpRgjLb8fFK6vRgTFoNnwpRFrxpEpFn62O8iQ1ylauXQAN5NxMZRKsRedAL6fplBMRhmPlHRI3Ed_R045NqcRagxhkPpWy4-nol6Rff9W_ePPo_8m2yefxupj8eHH14TG5wVE9E05RbZKNrlu4JhH1d8TRo9m8_IVDD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physical+rehabilitation+program+for+cardiorespiratory+health+and+quality+of+life+among+breast+cancer+survivors+in+UAE%3A+a+randomized+control+trial&rft.jtitle=BMC+cancer&rft.au=Rashid%2C+Fatima+Abdul&rft.au=Anwar%2C+Wajiha&rft.au=Kandakurti%2C+Praveen+Kumar&rft.au=Al+Qawasmeh%2C+Khaled+H+A&rft.date=2025-04-16&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=25&rft.issue=1&rft.spage=705&rft_id=info:doi/10.1186%2Fs12885-025-14005-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon